129 related articles for article (PubMed ID: 18406354)
1. Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR.
Rohrberg J; Sachs R; Lodderstedt G; Sackewitz M; Balbach J; Schwarz E
FEBS Lett; 2008 May; 582(11):1587-92. PubMed ID: 18406354
[TBL] [Abstract][Full Text] [Related]
2. Structural and dynamical characterization of fibrils from a disease-associated alanine expansion domain using proteolysis and solid-state NMR spectroscopy.
Sackewitz M; Scheidt HA; Lodderstedt G; Schierhorn A; Schwarz E; Huster D
J Am Chem Soc; 2008 Jun; 130(23):7172-3. PubMed ID: 18481858
[TBL] [Abstract][Full Text] [Related]
3. Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension.
Lodderstedt G; Sachs R; Faust J; Bordusa F; Kühn U; Golbik R; Kerth A; Wahle E; Balbach J; Schwarz E
Biochemistry; 2008 Feb; 47(7):2181-9. PubMed ID: 18205394
[TBL] [Abstract][Full Text] [Related]
4. Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1.
Lodderstedt G; Hess S; Hause G; Scheuermann T; Scheibel T; Schwarz E
FEBS J; 2007 Jan; 274(2):346-55. PubMed ID: 17229142
[TBL] [Abstract][Full Text] [Related]
5. Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1).
Winter R; Kühn U; Hause G; Schwarz E
J Biol Chem; 2012 Jun; 287(27):22662-71. PubMed ID: 22570486
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD.
Impagliazzo A; Tepper AW; Verrips TC; Ubbink M; van der Maarel SM
FEBS Lett; 2010 Apr; 584(8):1558-64. PubMed ID: 20226184
[TBL] [Abstract][Full Text] [Related]
7. Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation.
Scheuermann T; Schulz B; Blume A; Wahle E; Rudolph R; Schwarz E
Protein Sci; 2003 Dec; 12(12):2685-92. PubMed ID: 14627730
[TBL] [Abstract][Full Text] [Related]
8. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
[TBL] [Abstract][Full Text] [Related]
9. Poly-(L-alanine) expansions form core beta-sheets that nucleate amyloid assembly.
Shinchuk LM; Sharma D; Blondelle SE; Reixach N; Inouye H; Kirschner DA
Proteins; 2005 Nov; 61(3):579-89. PubMed ID: 16114037
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
[TBL] [Abstract][Full Text] [Related]
11. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
[TBL] [Abstract][Full Text] [Related]
12. The unresolved puzzle why alanine extensions cause disease.
Winter R; Liebold J; Schwarz E
Biol Chem; 2013 Aug; 394(8):951-63. PubMed ID: 23612654
[TBL] [Abstract][Full Text] [Related]
13. Conformational stability of the RNP domain controls fibril formation of PABPN1.
Liebold J; Winter R; Golbik R; Hause G; Parthier C; Schwarz E
Protein Sci; 2015 Nov; 24(11):1789-99. PubMed ID: 26267866
[TBL] [Abstract][Full Text] [Related]
14. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
[TBL] [Abstract][Full Text] [Related]
15. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
[TBL] [Abstract][Full Text] [Related]
16. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence.
Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y
J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043
[TBL] [Abstract][Full Text] [Related]
17. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
[TBL] [Abstract][Full Text] [Related]
18. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
van der Sluijs BM; van Engelen BG; Hoefsloot LH
Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
[TBL] [Abstract][Full Text] [Related]
19. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation.
Robinson DO; Hilton-Jones D; Mansfield D; Hildebrand GD; Marks S; Mechan D; Ramsay J
Neuromuscul Disord; 2011 Nov; 21(11):809-11. PubMed ID: 21742497
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species.
Rekas A; Jankova L; Thorn DC; Cappai R; Carver JA
FEBS J; 2007 Dec; 274(24):6290-304. PubMed ID: 18005258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
